In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma
NCT07715630
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsed or Refractory Multiple Myeloma (RRMM)
Interventions
BIOLOGICAL:
Invivo CAR-T
Sponsor
Chongqing Precision Biotech Co., Ltd